Editorial: Component transfusion therapy

August 1974
British Medical Journal;8/31/1974, Vol. 3 Issue 5930, p544
Academic Journal
No abstract available.


Related Articles

  • Erratum.  // Laboratory Medicine;Jan2011, Vol. 42 Issue 1, p55 

    A correction to the article "Update and Utilization of Component Therapy in Blood Transfusions" which published in a 2010 issue is presented.

  • Serious Error in CE Update for December 2010. Sazama, Kathleen; Gurevitz, Stacy A.; Wians, Jr., Frank H. // Laboratory Medicine;Mar2011, Vol. 42 Issue 3, p149 

    A letter to the editor and a reply are presented in response to the article "Update and utilization of component therapy in blood transfusions," by S. A. Gurevitz.

  • Information Update.  // Laboratory Medicine;May2011, Vol. 42 Issue 5, p315 

    The article presents a note for the article "Update and utilization of component therapy in blood transfusions" appeared in the April 2011 issue.

  • Recent Developments in Blood Components Therapy. Sturgeon, Phillip; Adashek, Eugene P.; Self, James L.; Stiehm, E. Richard; Tishkoff, Garson H. // Annals of Internal Medicine;Jan71, Vol. 74 Issue 1, p113 

    Discusses the advances in blood components therapy. Case of a patient that develop a hemolytic transfusion reaction and acute tubular necrosis; Red cells and the hazards of isoimmunization; Coagulation factors and massive blood transfusions.

  • blood component therapy.  // Taber's Cyclopedic Medical Dictionary;2005, p265 

    A definition of the medical term "blood component therapy" is presented. Blood component therapy is the transfusion of one or more of the components of whole blood. The blood components may have been taken from the patient previously (autologous transfusion) or donated by someone else...

  • Problems in transfusion therapy. Charache, S. // New England Journal of Medicine;6/7/90, Vol. 322 Issue 23, p1666 

    Editorial. Discusses two articles in this issue of the `Journal' by Surgenor et al and Vichinsky et al that explore questions about the hazards of transfusion therapy. Sickle cell disease; Acquired immunodeficiency syndrome.

  • Look-back notification: How do we assess effectiveness? King, Susan M. // CMAJ: Canadian Medical Association Journal;07/15/97, Vol. 157 Issue 2, p155 

    Editorial. Analyzes the method of notification to recipients of blood and blood components about risks of transfusions already received. How to measure the effectiveness of look-back notification programs; A reference to the Canadian study in the same issue on page 149.

  • Blood Components for Hemostasis. Eldin, Karen W.; Teruya, Jun // Laboratory Medicine;Fall2012, Vol. 43 Issue 6, p237 

    We present an overview of revised indications and doses for routinely transfused blood components. Targeted blood component therapy is one of the earliest models of personalized medicine, striving to achieve the tenets of the right dose at the right time for the right reason to the right...

  • Blood component therapy: Which, when and how much. Arya, Rajesh Chand; Wander, G. S.; Gupta, Pankaj // Journal of Anaesthesiology Clinical Pharmacology;Apr2011, Vol. 27 Issue 2, p278 

    Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating...

  • Your guide to trouble-free transfusions. Harovas, Joan; Anthony, Helene H.; O'Connor, Eileen // RN;Nov93, Vol. 56 Issue 11, p26 

    Presents a step-by-step guide and explanations about transfusion therapy. Identification of blood component for every symptom; Preparation; Evaluation of IV access in terms of patient's total treatment plan; Temperature and filtering; Adjustment of the flow-rate clamp during transfusion;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics